Research Commercialisation at the College of Medicine and Veterinary Medicine is supported by Sunergos Innovations, Edinburgh Research and Innovation, and the Entrepreneur in Residence scheme.
College support for commercialisation of its research is under the umbrella of Sunergos Innovations, a partnership between the University of Edinburgh and NHS Lothian.
Sunergos Innovations translates medical innovation into better health outcomes for patients in key areas including regenerative medicine, inflammation and oncology. We work with medical researchers, investors and the pharma industry to deliver new drugs, diagnostic tools and medical devices to the global healthcare market.
Edinburgh Research and Innovation (ERI) is the University's commercial liaison unit.
It puts any new University discoveries through a rigorous market evaluation to assess commercial viability and determine effective strategies for commercialisation.
ERI serves as the primary point of contact for industry and business with an interest in the commercialisation of the University's research activities.
The three year Entrepreneur in Residence (EiR) programme assists in the creation of life science businesses. It aims to build life science business proposals that originate from College intellectual assets, are aligned with market needs, and seek to utilise Scotland-wide and international assets.
The current EiR is Dr Howard Marriage, a businessman with over three decades of experience in life sciences research and commercialisation.